Celsius (NASDAQ:CELH) Stock Rating Reaffirmed by Wedbush

Wedbush reiterated their outperform rating on shares of Celsius (NASDAQ:CELH) in a report released on Friday, Benzinga reports. The brokerage currently has a $100.00 price objective on the stock.

A number of other brokerages have also weighed in on CELH. Maxim Group boosted their target price on shares of Celsius from $100.00 to $110.00 and gave the company a buy rating in a research note on Monday, April 1st. Stifel Nicolaus lowered their target price on Celsius from $95.00 to $85.00 and set a buy rating on the stock in a report on Thursday. Roth Mkm raised their target price on Celsius from $90.00 to $105.00 and gave the stock a buy rating in a research report on Thursday, March 14th. Jefferies Financial Group upped their price target on shares of Celsius from $98.00 to $105.00 and gave the company a buy rating in a research report on Monday, March 18th. Finally, Bank of America lowered shares of Celsius from a buy rating to a neutral rating and set a $65.00 target price for the company. in a research report on Friday, January 19th. Two investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of Moderate Buy and an average target price of $85.45.

Celsius Price Performance

CELH stock opened at $75.97 on Friday. The stock has a market capitalization of $17.55 billion, a P/E ratio of 98.24, a P/E/G ratio of 2.22 and a beta of 1.93. Celsius has a 1-year low of $32.99 and a 1-year high of $99.62. The business has a fifty day moving average price of $80.79 and a 200-day moving average price of $65.58.

Celsius (NASDAQ:CELH) last issued its earnings results on Thursday, February 29th. The company reported $0.17 earnings per share for the quarter, topping analysts’ consensus estimates of $0.16 by $0.01. Celsius had a return on equity of 131.58% and a net margin of 17.21%. The business had revenue of $347.44 million during the quarter, compared to analyst estimates of $326.77 million. During the same quarter in the previous year, the firm earned $0.01 EPS. Celsius’s revenue was up 95.2% on a year-over-year basis. As a group, analysts anticipate that Celsius will post 1.09 earnings per share for the current year.

Insiders Place Their Bets

In other news, Director Caroline S. Levy sold 20,000 shares of the business’s stock in a transaction dated Wednesday, March 13th. The stock was sold at an average price of $94.77, for a total value of $1,895,400.00. Following the transaction, the director now directly owns 37,891 shares in the company, valued at $3,590,930.07. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In related news, Director Caroline S. Levy sold 20,000 shares of the business’s stock in a transaction that occurred on Wednesday, March 13th. The stock was sold at an average price of $94.77, for a total value of $1,895,400.00. Following the transaction, the director now directly owns 37,891 shares of the company’s stock, valued at approximately $3,590,930.07. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, major shareholder William H. Milmoe sold 428,568 shares of the stock in a transaction that occurred on Wednesday, May 1st. The shares were sold at an average price of $59.67, for a total transaction of $25,572,652.56. Following the sale, the insider now directly owns 25,035,885 shares of the company’s stock, valued at $1,493,891,257.95. The disclosure for this sale can be found here. In the last quarter, insiders sold 1,186,215 shares of company stock worth $80,215,119. Corporate insiders own 2.20% of the company’s stock.

Institutional Trading of Celsius

Several hedge funds have recently bought and sold shares of the stock. Commonwealth Equity Services LLC boosted its stake in Celsius by 93.1% during the third quarter. Commonwealth Equity Services LLC now owns 106,706 shares of the company’s stock valued at $18,311,000 after buying an additional 51,451 shares during the last quarter. Cambridge Investment Research Advisors Inc. increased its position in Celsius by 89.1% in the third quarter. Cambridge Investment Research Advisors Inc. now owns 16,386 shares of the company’s stock worth $2,812,000 after purchasing an additional 7,723 shares during the last quarter. Raymond James Financial Services Advisors Inc. raised its stake in Celsius by 8.0% during the third quarter. Raymond James Financial Services Advisors Inc. now owns 53,237 shares of the company’s stock valued at $9,135,000 after purchasing an additional 3,921 shares in the last quarter. Bank of New York Mellon Corp lifted its position in Celsius by 8.5% during the third quarter. Bank of New York Mellon Corp now owns 428,602 shares of the company’s stock valued at $73,548,000 after purchasing an additional 33,597 shares during the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank grew its stake in shares of Celsius by 48.4% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 8,100 shares of the company’s stock worth $1,390,000 after buying an additional 2,643 shares in the last quarter. Hedge funds and other institutional investors own 60.95% of the company’s stock.

Celsius Company Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.